Endometrial cancer staging has changed over time to a surgicopathologic staging system. The goal of staging is to have a clinical practice guideline which reduces inappropriate variation in clinical practice and also to have uniformity in reporting results of treatment worldwide. In addition staging intends to prognosticate disease. Presently endometrial carcinoma is surgically staged according to the joint 2010 International Federation of Gynecology and Obstetrics (FIGO)/TNM classification system [1, 2]. The revised staging eliminated cervical glandular involvement and ascitic fluid cytology from staging, grouped together both IA and IB of the previous staging as IA, and substratified Stage IIIC. This staging system for endometrial cancers has been found to be highly prognostic in the case of endometrioid tumors . But size of tumor and LVSI (lymphovascular space invasion), which are also considered as prognostic factors, are not included in the current staging.
KeywordsEndometrial Cancer Endometrial Carcinoma Distant Lymph Node Clear Cell Adenocarcinoma Nearby Lymph Node